Why detransition became an untouchable subject in gender care: special report

Robin Respaut Chad Terhune Michelle Conlin
Dr Kinnon MacKinnon. Photo: York University

The public debate on the rights and wrongs of gender-affirming care is often reduced to the small number of patients who decide to detransition.

The experiences of Keira Bell — the former patient at the Tavistock Gender Clinic in the UK who detransitioned after undergoing a double mastectomy — have loomed large in the media.

For critics, such cases are meant to expose a treatment model gone wrong, with the implication that young people presenting at gender clinics end up on a clinical conveyor belt they cannot escape.

Studies suggest detransition is a rarity, with the World Professional Association for Transgender Health (WPATH) guidelines saying regret rates are possibly no higher than 1% and 1.5%.